Related Experiment Video
Updated: Feb 6, 2026

In vitro Cell Migration and Invasion Assays
Published on: June 1, 2014
Glabridin inhibits osteosarcoma migration and invasion via blocking the p38- and JNK-mediated CREB-AP1 complexes
Zhiwei Jie1,2, Ziang Xie1,2, Xiangde Zhao1,2
1Department of Orthopaedics, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Abstract:
Osteosarcoma is the most common bone malignancy, and it seriously affects the quality of life of affected children and adolescents. Glabridin (GLA), a major component of licorice root extract, has been reported to exert antitumor effects against a variety of tumor types; however, its effects on osteosarcoma have not been elucidated. In the current study, we investigate the effects and potential antimetastatic mechanisms of GLA on osteosarcoma in vitro and in vivo. Flow cytometry showed that GLA induced G2/M cell cycle phase arrest and promoted cell apoptosis. Transwell and wound-healing assays showed that GLA significantly decreased the migration and invasion of osteosarcoma cells. Further western blotting and quantitative real-time polymerase chain reaction showed that the expression of matrix metalloproteinase (MMP)-2 and MMP-9 in MG63 and HOS cells were reduced after GLA treatment. Moreover, western blotting demonstrated that GLA downregulated the phosphorylation of p38 mitogen-activated protein kinases and c-Jun N-terminal kinase. A coimmunoprecipitation assay illustrated that formation of cAMP response element-binding protein (CREB)-activating protein 1 (AP1) complexes and the DNA binding activities of CREB and AP1 in MG63 and HOS cells were impaired following treatment with GLA. Finally, GLA inhibited tumor growth and suppressed osteosarcoma cell metastasis in vivo. Overall, our findings highlight the potential of GLA as a therapeutic agent for the prevention and treatment of tumor metastasis.
Insights
Glabridin (GLA), from licorice root, inhibits osteosarcoma growth and metastasis by inducing cell cycle arrest, apoptosis, and reducing invasion. This study reveals GLA
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Osteosarcoma is a prevalent bone cancer impacting children and adolescents.
- Glabridin (GLA), a licorice root compound, shows antitumor potential but its effect on osteosarcoma is unknown.
Purpose of the Study:
- To investigate the anti-osteosarcoma and anti-metastatic effects of Glabridin (GLA).
- To elucidate the underlying molecular mechanisms of GLA's action against osteosarcoma.
Main Methods:
- In vitro studies using osteosarcoma cell lines (MG63, HOS) and in vivo mouse models.
- Flow cytometry for cell cycle and apoptosis analysis.
- Transwell and wound-healing assays for migration and invasion.
- Western blotting, qRT-PCR, and co-immunoprecipitation for molecular analysis.
Main Results:
- GLA induced G2/M cell cycle arrest and apoptosis in osteosarcoma cells.
- GLA significantly reduced osteosarcoma cell migration and invasion.
- GLA decreased matrix metalloproteinase (MMP)-2 and MMP-9 expression.
- GLA downregulated p38 MAPK and JNK phosphorylation, and impaired CREB/AP1 complex formation and DNA binding.
Conclusions:
- Glabridin (GLA) demonstrates significant anti-tumor and anti-metastatic potential in osteosarcoma.
- GLA acts by disrupting cell cycle progression, promoting apoptosis, and inhibiting key signaling pathways involved in invasion.
- GLA shows promise as a therapeutic agent for osteosarcoma metastasis prevention and treatment.
Related Concept Videos
Formation of Complex Ions
Feedback Inhibition
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Migration
Enzyme Inhibition
Block Diagram Reduction
The first step in this process is the identification and relocation of a branch point. A branch point, where a...

